ticagrelor - Robuta Search

https://adisinsight.springer.com/drugsafety/803730068?error=cookies_not_supported&code=40e97237-810d-40b9-84ed-22631798379b Ticagrelor - AdisInsight An 80-year-old woman developed transient dyspnoea during antiplatelet therapy with ticagrelor.The woman without known cardiovascular atherosclerotic risk ticagrelor adisinsight https://boris-portal.unibe.ch/entities/publication/a9440ace-0151-4bf6-ab43-0fcbd59a05c0 Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by... Patients undergoing staged percutaneous coronary intervention (SPCI) are exposed to extended duration of antiplatelet therapy, and a novel aspirin-free... safety and efficacy https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Ticagrelor DailyMed - Search Results for Ticagrelor search results dailymed ticagrelor https://portal.fis.tum.de/en/publications/morphine-and-ticagrelor-interaction-in-primary-percutaneous-coron/ Morphine and Ticagrelor Interaction in Primary Percutaneous Coronary Intervention in ST-Segment... coronary intervention morphine ticagrelor interaction https://portal.fis.tum.de/en/publications/the-effect-of-a-prasugrel-vs-a-ticagrelor-based-strategy-on-total/ The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events... https://blogs.bmj.com/heart/tag/ticagrelor/ ticagrelor Archives - Heart ticagrelor archives heart https://pubmed.ncbi.nlm.nih.gov/27057966/ Clinically significant ticagrelor induced conduction abnormalities following percutaneous coronary... Clinically significant ticagrelor induced conduction abnormalities following percutaneous coronary intervention significant ticagrelor induced conduction abnormalities https://researchconnect.buffalo.edu/en/publications/an-alternative-reduced-dose-regimen-of-ticagrelor-for-neuroendova/ An alternative reduced dose regimen of ticagrelor for neuroendovascular patients - SUNY University... an alternative https://pubmed.ncbi.nlm.nih.gov/37196530/ Ticagrelor as Compared to Clopidogrel Following Percutaneous Coronary Intervention for Acute... Dual antiplatelet therapy with acetylsalicylic acid and a P2Y12 inhibitor has become a mainstay of therapy after percutaneous coronary intervention (PCI) for... compared to coronary intervention ticagrelor clopidogrel https://www.sciencedaily.com/releases/2015/08/150831101829.htm Ticagrelor administered in the ambulance reduces ischaemic events 24 hours after PCI | ScienceDaily Ticagrelor administered in the ambulance reduces ischaemic events 24 hours after primary percutaneous coronary intervention (PCI), according to new findings. https://boris-portal.unibe.ch/entities/publication/3db76b1a-60e0-410a-bc3a-8f2d348ec6ff Upstream clopidogrel, prasugrel, or ticagrelor for patients treated with primary angioplasty:... OBJETIVES The main objective of the present randomized pilot study was to explore the effects of upstream prasugrel or ticagrelor or clopidogrel for patients... for patients upstream clopidogrel prasugrel ticagrelor https://adisinsight.springer.com/drugsafety/803856460?error=cookies_not_supported&code=1a70eec8-e33f-4288-a04d-80f8f844124c Ticagrelor/triflusal - AdisInsight A 70 year-old man exhibited lack of efficacy during treatment with ticagrelor and triflusal for inferior ST-segment elevation myocardial infarction.The man, who ticagrelor adisinsight https://adisinsight.springer.com/trials/700248697?error=cookies_not_supported&code=ac327328-a770-429f-ac8e-40221d4f3e68 Comparison of Antiplatelet Therapy With Clopidogrel and Ticagrelor in Patients After Cardiac Arrest... This study is comparing clopidogrel [Plavix] and ticagrelor [Brilique] for an antiplatelet therapy in patients after cardiac arrest treated with therapeutic https://adisinsight.springer.com/drugsafety/803270249?error=cookies_not_supported&code=bbf8c7fd-3c45-43a0-8048-4ef55b0b0c59 Atorvastatin/clarithromycin/ticagrelor interaction - AdisInsight A 72-year-old man developed rhabdomyolysis following co-administration of atorvastatin, clarithromycin and ticagrelor [routes not stated].The man, who had a atorvastatin clarithromycin ticagrelor interaction adisinsight https://scholars.duke.edu/publication/1274088 Scholars@Duke publication: The PARTHENON Clinical Development Program: the Role of Ticagrelor in... the parthenon clinical development https://scholars.uky.edu/en/publications/ticagrelor-monotherapy-after-pci-in-patients-with-concomitant-dia/ Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney... https://pubmed.ncbi.nlm.nih.gov/33633048/ Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary... Discontinuation of both cangrelor and ticagrelor because of severe dyspnea during primary angioplasty discontinuation https://pubmed.ncbi.nlm.nih.gov/31845894/ Ticagrelor monotherapy beyond one month after PCI in ACS or stable CAD in elderly patients: a... In this pre-specified, exploratory analysis of the overall neutral trial, there was no differential treatment effect of ticagrelor monotherapy (after one-month... https://researchdiscovery.drexel.edu/esploro/outputs/journalArticle/Ticagrelor-Versus-Clopidogrel-in-Elderly-Patients/991020786008204721 Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes A Substudy From the... Sep 1, 2012 - Background-Elderly patients with acute coronary syndrome are at high risk of recurrent ischemic events and death, and for both antithrombotic therapy and... https://pubmed.ncbi.nlm.nih.gov/37446022/ Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report Ticagrelor is currently considered a first-line choice in dual antiplatelet therapy (DAPT) following revascularization of acute coronary syndrome (ACS).... https://dukespace.lib.duke.edu/items/a6fe8f7e-fafe-4900-b698-27b3b770cac0 Lifetime cost-effectiveness analysis of ticagrelor in patients with acute coronary syndromes based... https://hsrc.himmelfarb.gwu.edu/gwhpubs/3209/ "Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute " by Amarjeet Tank, S... OBJECTIVE: THALES demonstrated that ticagrelor plus aspirin reduced the risk of stroke or death but increased bleeding versus aspirin during the 30 days... https://portal.fis.tum.de/en/publications/prior-myocardial-infarction-and-treatment-effect-of-ticagrelor-ve/ Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With... https://research.utwente.nl/en/publications/rationale-and-design-of-the-stop-imh-randomised-trial-safety-of-t/ Rationale and design of the STOP-IMH randomised trial: Safety of ticagrelor monotherapy after... https://adisinsight.springer.com/trials/700241155?error=cookies_not_supported&code=2db90996-02c0-4b54-9f9c-21b4f39f3412 Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET Trial): Does... This study is investigating the efficacy of aspirin versus ticagrelor for the prevention of saphenous vein graft occlusion in patients undergoing coronary https://scholars.duke.edu/publication/1322484 Scholars@Duke publication: Ticagrelor Use in Acute Myocardial Infarction: Insights From the... acute myocardial infarction